Asia-Pacific Cancer Vaccines Market Report 2017

November 2017 | 114 pages | ID: AF8F9145FE6EN
QYResearch

Abstracts

In this report, the Asia-Pacific Cancer Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Cancer Vaccines for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Cancer Vaccines market competition by top manufacturers/players, with Cancer Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Dendreon
• GlaxoSmithKline
• Merck
• Sanofi
• Amgen
• Biothera
• Isa Pharmaceuticals
• Bristol-Myers Squibb
• Bavarian Nordic
• Antigen Express
• Juvaris Biotherapeutics
• Provectus Biopharmaceuticals
• Aduro BioTech
• Galena Biopharma
• Northwest Biotherapeutics
• Oxford BioMedica
• Inovio Pharmaceuticals
• Vaxon Biotech
• Celldex Therapeutics
• Prima BioMed

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

• Rophylactic Vaccines
• Therapeutic Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Adults
• Children

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Cancer Vaccines Market Report 2017

1 CANCER VACCINES OVERVIEW

1.1 Product Overview and Scope of Cancer Vaccines
1.2 Classification of Cancer Vaccines by Product Category
  1.2.1 Asia-Pacific Cancer Vaccines Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Cancer Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Rophylactic Vaccines
  1.2.4 Therapeutic Vaccines
1.3 Asia-Pacific Cancer Vaccines Market by Application/End Users
  1.3.1 Asia-Pacific Cancer Vaccines Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Adults
  1.3.3 Children
1.4 Asia-Pacific Cancer Vaccines Market by Region
  1.4.1 Asia-Pacific Cancer Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Cancer Vaccines (2012-2022)
  1.5.1 Asia-Pacific Cancer Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Cancer Vaccines Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC CANCER VACCINES COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Cancer Vaccines Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Cancer Vaccines Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Cancer Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Cancer Vaccines (Volume and Value) by Type
  2.2.1 Asia-Pacific Cancer Vaccines Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Cancer Vaccines Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Cancer Vaccines (Volume) by Application
2.4 Asia-Pacific Cancer Vaccines (Volume and Value) by Region
  2.4.1 Asia-Pacific Cancer Vaccines Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Cancer Vaccines Revenue and Market Share by Region (2012-2017)

3 CHINA CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 China Cancer Vaccines Sales and Value (2012-2017)
  3.1.1 China Cancer Vaccines Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Cancer Vaccines Revenue and Growth Rate (2012-2017)
  3.1.3 China Cancer Vaccines Sales Price Trend (2012-2017)
3.2 China Cancer Vaccines Sales Volume and Market Share by Type
3.3 China Cancer Vaccines Sales Volume and Market Share by Application

4 JAPAN CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Cancer Vaccines Sales and Value (2012-2017)
  4.1.1 Japan Cancer Vaccines Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Cancer Vaccines Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Cancer Vaccines Sales Price Trend (2012-2017)
4.2 Japan Cancer Vaccines Sales Volume and Market Share by Type
4.3 Japan Cancer Vaccines Sales Volume and Market Share by Application

5 SOUTH KOREA CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Cancer Vaccines Sales and Value (2012-2017)
  5.1.1 South Korea Cancer Vaccines Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Cancer Vaccines Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Cancer Vaccines Sales Price Trend (2012-2017)
5.2 South Korea Cancer Vaccines Sales Volume and Market Share by Type
5.3 South Korea Cancer Vaccines Sales Volume and Market Share by Application

6 TAIWAN CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Cancer Vaccines Sales and Value (2012-2017)
  6.1.1 Taiwan Cancer Vaccines Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Cancer Vaccines Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Cancer Vaccines Sales Price Trend (2012-2017)
6.2 Taiwan Cancer Vaccines Sales Volume and Market Share by Type
6.3 Taiwan Cancer Vaccines Sales Volume and Market Share by Application

7 INDIA CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 India Cancer Vaccines Sales and Value (2012-2017)
  7.1.1 India Cancer Vaccines Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Cancer Vaccines Revenue and Growth Rate (2012-2017)
  7.1.3 India Cancer Vaccines Sales Price Trend (2012-2017)
7.2 India Cancer Vaccines Sales Volume and Market Share by Type
7.3 India Cancer Vaccines Sales Volume and Market Share by Application

8 SOUTHEAST ASIA CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Cancer Vaccines Sales and Value (2012-2017)
  8.1.1 Southeast Asia Cancer Vaccines Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Cancer Vaccines Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Cancer Vaccines Sales Price Trend (2012-2017)
8.2 Southeast Asia Cancer Vaccines Sales Volume and Market Share by Type
8.3 Southeast Asia Cancer Vaccines Sales Volume and Market Share by Application

9 AUSTRALIA CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Cancer Vaccines Sales and Value (2012-2017)
  9.1.1 Australia Cancer Vaccines Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Cancer Vaccines Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Cancer Vaccines Sales Price Trend (2012-2017)
9.2 Australia Cancer Vaccines Sales Volume and Market Share by Type
9.3 Australia Cancer Vaccines Sales Volume and Market Share by Application

10 ASIA-PACIFIC CANCER VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Dendreon
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Cancer Vaccines Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Dendreon Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 GlaxoSmithKline
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Cancer Vaccines Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 GlaxoSmithKline Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Merck
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Cancer Vaccines Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Merck Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Sanofi
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Cancer Vaccines Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Sanofi Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Amgen
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Cancer Vaccines Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Amgen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Biothera
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Cancer Vaccines Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Biothera Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Isa Pharmaceuticals
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Cancer Vaccines Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Isa Pharmaceuticals Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Bristol-Myers Squibb
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Cancer Vaccines Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Bristol-Myers Squibb Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Bavarian Nordic
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Cancer Vaccines Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Bavarian Nordic Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Antigen Express
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Cancer Vaccines Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Antigen Express Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Juvaris Biotherapeutics
10.12 Provectus Biopharmaceuticals
10.13 Aduro BioTech
10.14 Galena Biopharma
10.15 Northwest Biotherapeutics
10.16 Oxford BioMedica
10.17 Inovio Pharmaceuticals
10.18 Vaxon Biotech
10.19 Celldex Therapeutics
10.20 Prima BioMed

11 CANCER VACCINES MANUFACTURING COST ANALYSIS

11.1 Cancer Vaccines Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cancer Vaccines

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Cancer Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC CANCER VACCINES MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Cancer Vaccines Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Cancer Vaccines Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Cancer Vaccines Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Cancer Vaccines Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Cancer Vaccines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Cancer Vaccines Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Cancer Vaccines Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Cancer Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Cancer Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Cancer Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Cancer Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Cancer Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Cancer Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Cancer Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Cancer Vaccines Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Cancer Vaccines Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Cancer Vaccines Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Cancer Vaccines Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Cancer Vaccines Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Cancer Vaccines
Figure Asia-Pacific Cancer Vaccines Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Cancer Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Rophylactic Vaccines Product Picture
Figure Therapeutic Vaccines Product Picture
Figure Asia-Pacific Cancer Vaccines Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Cancer Vaccines by Application in 2016
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Children Examples
Table Key Downstream Customer in Children
Figure Asia-Pacific Cancer Vaccines Market Size (Million USD) by Region (2012-2022)
Figure China Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Cancer Vaccines Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Cancer Vaccines Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Cancer Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Cancer Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Cancer Vaccines Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Cancer Vaccines Sales Share by Players/Suppliers
Figure Asia-Pacific Cancer Vaccines Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Cancer Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Cancer Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Cancer Vaccines Revenue Share by Players
Figure 2017 Asia-Pacific Cancer Vaccines Revenue Share by Players
Table Asia-Pacific Cancer Vaccines Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Cancer Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Cancer Vaccines by Type (2012-2017)
Figure Asia-Pacific Cancer Vaccines Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Cancer Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Cancer Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Vaccines by Type (2012-2017)
Figure Asia-Pacific Cancer Vaccines Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Cancer Vaccines Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Cancer Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Cancer Vaccines by Region (2012-2017)
Figure Asia-Pacific Cancer Vaccines Sales Market Share by Region in 2016
Table Asia-Pacific Cancer Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Cancer Vaccines Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Cancer Vaccines by Region (2012-2017)
Figure Asia-Pacific Cancer Vaccines Revenue Market Share by Region in 2016
Table Asia-Pacific Cancer Vaccines Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Cancer Vaccines Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Cancer Vaccines Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Cancer Vaccines Sales Market Share by Application (2012-2017)
Figure China Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure China Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Cancer Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table China Cancer Vaccines Sales Volume (K Units) by Type (2012-2017)
Table China Cancer Vaccines Sales Volume Market Share by Type (2012-2017)
Figure China Cancer Vaccines Sales Volume Market Share by Type in 2016
Table China Cancer Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table China Cancer Vaccines Sales Volume Market Share by Application (2012-2017)
Figure China Cancer Vaccines Sales Volume Market Share by Application in 2016
Figure Japan Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Cancer Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Cancer Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Japan Cancer Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Japan Cancer Vaccines Sales Volume Market Share by Type in 2016
Table Japan Cancer Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Japan Cancer Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Japan Cancer Vaccines Sales Volume Market Share by Application in 2016
Figure South Korea Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Cancer Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Cancer Vaccines Sales Volume (K Units) by Type (2012-2017)
Table South Korea Cancer Vaccines Sales Volume Market Share by Type (2012-2017)
Figure South Korea Cancer Vaccines Sales Volume Market Share by Type in 2016
Table South Korea Cancer Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Cancer Vaccines Sales Volume Market Share by Application (2012-2017)
Figure South Korea Cancer Vaccines Sales Volume Market Share by Application in 2016
Figure Taiwan Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Cancer Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Cancer Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Cancer Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Cancer Vaccines Sales Volume Market Share by Type in 2016
Table Taiwan Cancer Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Cancer Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Cancer Vaccines Sales Volume Market Share by Application in 2016
Figure India Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure India Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Cancer Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table India Cancer Vaccines Sales Volume (K Units) by Type (2012-2017)
Table India Cancer Vaccines Sales Volume Market Share by Type (2012-2017)
Figure India Cancer Vaccines Sales Volume Market Share by Type in 2016
Table India Cancer Vaccines Sales Volume (K Units) by Application (2012-2017)
Table India Cancer Vaccines Sales Volume Market Share by Application (2012-2017)
Figure India Cancer Vaccines Sales Volume Market Share by Application in 2016
Figure Southeast Asia Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Cancer Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Cancer Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Cancer Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Cancer Vaccines Sales Volume Market Share by Type in 2016
Table Southeast Asia Cancer Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Cancer Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Cancer Vaccines Sales Volume Market Share by Application in 2016
Figure Australia Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Cancer Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Cancer Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Australia Cancer Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Australia Cancer Vaccines Sales Volume Market Share by Type in 2016
Table Australia Cancer Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Australia Cancer Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Australia Cancer Vaccines Sales Volume Market Share by Application in 2016
Table Dendreon Cancer Vaccines Basic Information List
Table Dendreon Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dendreon Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Dendreon Cancer Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Dendreon Cancer Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline Cancer Vaccines Basic Information List
Table GlaxoSmithKline Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Cancer Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline Cancer Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck Cancer Vaccines Basic Information List
Table Merck Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Cancer Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck Cancer Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi Cancer Vaccines Basic Information List
Table Sanofi Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Cancer Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi Cancer Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Amgen Cancer Vaccines Basic Information List
Table Amgen Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Cancer Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Amgen Cancer Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Biothera Cancer Vaccines Basic Information List
Table Biothera Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biothera Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Biothera Cancer Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Biothera Cancer Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Isa Pharmaceuticals Cancer Vaccines Basic Information List
Table Isa Pharmaceuticals Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Isa Pharmaceuticals Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Isa Pharmaceuticals Cancer Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Isa Pharmaceuticals Cancer Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Bristol-Myers Squibb Cancer Vaccines Basic Information List
Table Bristol-Myers Squibb Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Cancer Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Bristol-Myers Squibb Cancer Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Bavarian Nordic Cancer Vaccines Basic Information List
Table Bavarian Nordic Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bavarian Nordic Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Bavarian Nordic Cancer Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Bavarian Nordic Cancer Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Antigen Express Cancer Vaccines Basic Information List
Table Antigen Express Cancer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Antigen Express Cancer Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Antigen Express Cancer Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Antigen Express Cancer Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Juvaris Biotherapeutics Cancer Vaccines Basic Information List
Table Provectus Biopharmaceuticals Cancer Vaccines Basic Information List
Table Aduro BioTech Cancer Vaccines Basic Information List
Table Galena Biopharma Cancer Vaccines Basic Information List
Table Northwest Biotherapeutics Cancer Vaccines Basic Information List
Table Oxford BioMedica Cancer Vaccines Basic Information List
Table Inovio Pharmaceuticals Cancer Vaccines Basic Information List
Table Vaxon Biotech Cancer Vaccines Basic Information List
Table Celldex Therapeutics Cancer Vaccines Basic Information List
Table Prima BioMed Cancer Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Vaccines
Figure Manufacturing Process Analysis of Cancer Vaccines
Figure Cancer Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2016
Table Major Buyers of Cancer Vaccines
Table Distributors/Traders List
Figure Asia-Pacific Cancer Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Cancer Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Cancer Vaccines Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Cancer Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Cancer Vaccines Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Cancer Vaccines Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Cancer Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Cancer Vaccines Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Cancer Vaccines Revenue Market Share Forecast by Region in 2022
Figure China Cancer Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Cancer Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Cancer Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Cancer Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Cancer Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Cancer Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Cancer Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Cancer Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Cancer Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Cancer Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Cancer Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Cancer Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Cancer Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Cancer Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Cancer Vaccines Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Cancer Vaccines Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Cancer Vaccines Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Cancer Vaccines Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Cancer Vaccines Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Cancer Vaccines Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Cancer Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources